New in CME courses: Experts in the Hot Seat: Navigating PCSK9 Inhibitor Prescribing in Persistent Elevated LDL-C

Target audience:  Lipidologists, endocrinologists, cardiologists, nurse practitioners, physician assistants, registered dietitians, advanced practice registered nurses, registered nurses, and pharmacists who are members of the NLA, as well as a national cohort of providers who manage patients with high LDL cholesterolemia.

The goal of this activity is to provide evidence-based support and a clinical rationale for the use of use of PCSK9 inhibitors (PCSK9Is) in certain patients with hypercholesterolemia. Interactive case challenges will be used to demonstrate patient eligibility and required documentation for payers in eligible patients using clinical trial and tolerability data.

Expert faculty discuss barriers to the prescribing of PCSK9Is and methods for overcoming these barriers. Tools and resources that can be used to facilitate access to this important therapeutic option for the treatment of elevated LDL-C are also provided at the conclusion of this activity.

This activity – Experts in the Hot Seat: Navigating PCSK9 Inhibitor Prescribing in Persistent Elevated LDL-C, offers: 1.25 AMA PRA Category 1 Credit™, 1.25 ACPE contact hours, 1.3 ANCC contact hours.

Click here to start this activity!